Security

Real offensive depth

Testing and defence led by a published security researcher with six CVEs, including a CVSS 9.1 Mirai botnet kill-switch.

All security →
Compliance

Audit-ready, fixed scope

SOC 2, ISO, CPCSC, and the Canadian privacy stack, run end to end with an independent auditor.

All frameworks →
Resources

Learn the space

Original research, free tools, and plain-language guides on security and compliance, from a published security researcher.

Read the blog →
Compliance

How to Get SOC 2 for a Healthtech Company

Direct Answer: What It Takes for a Healthtech Company to Get SOC 2

A healthtech company earns SOC 2 attestation by first closing the gap between its current security posture and the Trust Services Criteria, then having an independent, licensed CPA firm audit its controls over a defined observation period. For healthtech specifically, the process is complicated by protected health information (PHI), the overlap between HIPAA-style expectations and SOC 2 scope, and Canadian privacy obligations under PIPEDA (or PHIPA in Ontario, or Quebec's Law 25 if you handle Quebec residents' data). Most healthtech founders start the clock the moment a hospital system, insurer, or enterprise health plan sends a security questionnaire that demands "SOC 2 or we cannot sign." The realistic path is: a fixed-scope gap analysis first, remediation second, and an independent CPA-led audit last. Budget 3 to 4 months for Type I and 9 to 12 months for Type II once controls are actually running.

Why Healthtech Buyers Ask for SOC 2 (Not Just HIPAA)

If you sell into US health systems, payers, or digital health platforms, you have likely already heard HIPAA mentioned in the same breath as SOC 2. Here is the trigger most healthtech founders describe: a hospital procurement team or a health plan's vendor risk group sends a security questionnaire, and buried in it is a line that says attestation is required before the contract can be signed. HIPAA has no independent certification body, so enterprise buyers increasingly lean on SOC 2 as the auditable proof point that a vendor's controls actually work, not just that a policy document exists. Investors preparing you for a Series A or B raise ask the same question from a different angle: can you show a signed SOC 2 report to a due diligence team without scrambling? Either way, the emotional core is the same. You are staring down a deal or a raise you cannot afford to lose, and you do not have six months to figure out compliance from scratch while also running product and clinical operations.

The Sector-Specific Gaps Healthtech Companies Usually Have

Healthtech organizations tend to fail readiness assessments in a few predictable places:

  • PHI data mapping is incomplete. Teams know PHI lives in the production database but cannot say where it flows through logs, analytics tools, support tickets, or third-party APIs.
  • Business associate and subprocessor agreements are missing or outdated. If you touch US patient data, every subprocessor needs a BAA on file; SOC 2 auditors will ask for the list and the paperwork.
  • Access controls lag behind clinical urgency. Healthtech teams often grant broad database access during incident response or customer support and never revoke it, which is one of the most common SOC 2 findings.
  • Encryption and key management are assumed, not evidenced. Encryption at rest and in transit needs to be documented and demonstrable, not just "on by default" in the cloud provider console.
  • Vendor risk management is thin. Healthtech stacks often include EHR integration partners, telehealth infrastructure, and lab data pipelines that were never formally risk-assessed.
  • Incident response has not been tested against a breach involving PHI specifically. A generic IR plan is not the same as one that accounts for breach notification obligations under provincial and US state law.

None of these gaps are unusual for an early or growth-stage healthtech company. They are the direct result of building fast for clinicians and patients while security tooling matures later. The fix is not to panic, it is to scope the gap precisely and close it in order of audit risk.

How to Get SOC 2: The Step-by-Step Process

Step 1: Run a fixed-scope gap analysis against the Trust Services Criteria

Before touching a single control, you need an honest map of where you stand against the five Trust Services Criteria, with Security as the mandatory baseline and Confidentiality or Privacy commonly added for healthtech given the sensitivity of PHI. A fixed-scope gap analysis, done by a prep-focused team rather than the eventual auditor, gives you a prioritized list of findings instead of a vague "you need to work on security" verdict. This is the step most healthtech teams skip, and it is the reason so many end up mid-audit with surprise findings that blow the timeline.

Step 2: Scope remediation and assign owners

Once you know the gaps, remediation gets scoped as its own project, separate from the assessment. For healthtech this usually means formalizing access reviews, standing up a vendor risk register that covers every subprocessor touching PHI, documenting encryption and key rotation practices, and writing (or rewriting) an incident response plan that names breach notification timelines. Remediation is where most of the calendar time goes, typically 6 to 10 weeks for a Type I-ready posture.

Step 3: Decide between Type I and Type II

Type I attests that controls are designed appropriately at a single point in time. Type II attests that those controls operated effectively over an observation window, usually 3 to 6 months for a first audit. Most enterprise health buyers will eventually want Type II, but many healthtech companies close their first urgent deal with a Type I report while the Type II observation period runs in parallel. This staged approach keeps a stalled deal moving without pretending you have a year of evidence you do not yet have.

Step 4: Bring in an independent CPA firm for the audit

SOC 2 reports must be issued by a licensed CPA firm, and that firm must be independent of whoever did your readiness work. This is a hard rule in the profession, not a preference. A prep partner scopes the assessment and closes gaps; a separate, independent auditor examines the evidence and signs the report. If the same firm did both, the report has no credibility with an enterprise vendor risk team. Our role at traztech is the prep side: the fixed-scope gap analysis, the remediation plan, and coordinating a qualified CPA firm for the actual attestation.

Step 5: Collect evidence and complete the audit

During the observation period, evidence collection should be continuous rather than a scramble at the end. Access logs, change management tickets, vendor risk assessments, and incident response tests all need to be captured as they happen. At the end of the window, the CPA firm reviews the evidence, tests the controls, and issues the report you can hand to enterprise buyers, investors, or partners.

Timeline: What to Actually Expect

For a Canadian healthtech company starting from a reasonably mature security baseline, a realistic timeline looks like: 2 to 3 weeks for the gap analysis, 6 to 10 weeks for remediation, and then either a short Type I audit window or a 3 to 6 month Type II observation period. End to end, that is roughly 3 to 4 months for Type I and 9 to 12 months for Type II. Companies that skip the gap analysis and go straight to the auditor almost always take longer, because findings surface mid-audit instead of before it.

The Canadian Angle: PIPEDA, PHIPA, and Cross-Border Health Data

Healthtech companies based in Toronto, Waterloo, Ottawa, Vancouver, Calgary, or Montreal that sell into the US market are managing two compliance layers at once: Canadian privacy law and US enterprise expectations. PIPEDA sets the federal baseline for personal information, PHIPA governs health information specifically in Ontario, and Quebec's Law 25 adds stricter consent and breach notification requirements if you touch Quebec residents' data. SOC 2 does not replace these obligations, but a well-scoped gap analysis usually surfaces where your privacy program and your SOC 2 controls overlap, particularly around data subject access, breach notification timing, and cross-border data transfer disclosures. Getting this right once, instead of building separate compliance tracks for Canada and the US, saves real time later.

Getting Started

If a health system, payer, or investor has already told you SOC 2 is the gate to close a deal or a round, the fastest path forward is a fixed-scope gap analysis that tells you exactly where you stand, what needs to be fixed, and how long it will realistically take. Learn more about how this fits into a broader program on our compliance solutions page, or if you are further along and comparing readiness partners, our contact page is the fastest way to talk it through with our team directly. For a no-cost first look at where your healthtech company stands against the Trust Services Criteria, book a free readiness call and get a clear, prioritized picture of the work ahead before you commit to an audit timeline you cannot control.

Not ready for a call? Same.

Get the playbook, not a sales pitch

If this was useful, Jacob sends a few short, practical notes on locking down your startup without a big security team. No fluff, unsubscribe in one click. Just reply if you want to talk; it reaches him directly.

From Jacob Masse, founder of traztech. No spam, unsubscribe in one click.

Need help with any of this?

We help startups build secure, scalable infrastructure. Book a free strategy call and let's talk about your stack.

Book a free consultation